Comparison of immune-related hepatitis and sclerosing choalngitis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040210096

Enrollment

1400

Registered

2021-11-02

Start date

2021-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with immunotherapy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient with immunotherapy

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
clinical course of hepatitis and sclerosing cholangitis	—

Contacts

Public ContactMasaki Takinami

Iwata city hospital

masaki.takinami@gmail.com+81-538385000

Outcome results